Coverage
-
May 18, 2026
The U.S. Supreme Court on Monday rejected six petitions from pharmaceutical giants seeking to bring down the Medicare drug price negotiations established as part of the Inflation Reduction Act three years ago.
2 other articles on this case.
View all »